PFIZ34:BVMF
Pfizer BDR
R$37.27
arrow_upward
+0.30%(+0.11) 1D
Sep 28, 12:11:51 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFIZ34...
Open
R$37.20
High
R$37.40
Low
R$37.01
Mkt. cap
162.78B
Avg. vol.
9.07K
Volume
1.50K
52-wk high
R$37.50
52-wk low
R$29.96
Shares outstanding
5.70B
No. of employees
75K
Open
R$37.20
High
R$37.40
Low
R$37.01
Mkt. cap
162.78B
Avg. vol.
9.07K
Volume
1.50K
52-wk high
R$37.50
52-wk low
R$29.96
Shares outstanding
5.70B
No. of employees
75K
News stories
From web sources and news partners
Yahoo Finance
·
3 hours ago
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
scanx.trade
·
3 hours ago
Pfizer Q2FY26 Results: Revenue tops estimates, guidance raised by $500 million
Benzinga
·
4 hours ago
Full Transcript: Pfizer Q2 2026 Earnings Call
Stock Titan
·
4 hours ago
Pfizer will give 11 cancer research talks in Madrid this October
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer BDR
CEOAlbert Bourla
Employees75K
Founded1849
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitepfizer.com